---
title: CD44-Mediated Metabolic Rewiring is A Targetable Dependency of IDH-Mutant Leukemia
date: '2025-01-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39841003/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20250123170657&v=2.18.0.post9+e462414
source: Blood
description: Recurrent IDH mutations catalyze NADPH-dependent production of oncometabolite
  R-2HG for tumorigenesis. IDH inhibition provides clinical response in a subset of
  acute myeloid leukemia (AML) cases; however, most patients develop resistance, highlighting
  the need for more effective IDH-targeting therapies. By comparing transcriptomic
  alterations in isogenic leukemia cells harboring CRISPR base-edited IDH mutations,
  we identify the activation of adhesion molecules including CD44, a ...
disable_comments: true
---
Recurrent IDH mutations catalyze NADPH-dependent production of oncometabolite R-2HG for tumorigenesis. IDH inhibition provides clinical response in a subset of acute myeloid leukemia (AML) cases; however, most patients develop resistance, highlighting the need for more effective IDH-targeting therapies. By comparing transcriptomic alterations in isogenic leukemia cells harboring CRISPR base-edited IDH mutations, we identify the activation of adhesion molecules including CD44, a ...